FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116113006: Oseltamivir phosphate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177277018 Oseltamivir phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
675077019 Oseltamivir phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
8331000188118 oseltamivir phosphate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
829811000172116 phosphate d'oseltamivir fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oseltamivir phosphate Is a médicament antiviral false Inferred relationship Some
Oseltamivir phosphate Is a Phosphate salt false Inferred relationship Some
Oseltamivir phosphate Is a Substance with antiviral mechanism of action (substance) false Inferred relationship Some
Oseltamivir phosphate Is a classe d'allergènes false Inferred relationship Some
Oseltamivir phosphate Is a Oseltamivir (substance) false Inferred relationship Some
Oseltamivir phosphate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Neuraminidase inhibitor (disposition) true Inferred relationship Some
Oseltamivir phosphate Is a Carboxylic ester (substance) true Inferred relationship Some
Oseltamivir phosphate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antiviral (disposition) true Inferred relationship Some
Oseltamivir phosphate Is a allergène médicamenteux false Inferred relationship Some
Oseltamivir phosphate Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Oseltamivir phosphate Is a Neuraminidase inhibitor true Inferred relationship Some
Oseltamivir phosphate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Oseltamivir (substance) true Inferred relationship Some
Oseltamivir phosphate Is a Acetamide (substance) true Inferred relationship Some
Oseltamivir phosphate Is a Glycosidase inhibitor false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Oseltamivir phosphate 12mg/mL powder for oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some
Oseltamivir phosphate 75mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some
Product containing oseltamivir (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some
Product containing precisely oseltamivir (as oseltamivir phosphate) 75 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some
Product containing precisely oseltamivir 12 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some
Product containing precisely oseltamivir 12 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some
Product containing precisely oseltamivir phosphate 30 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some
Product containing precisely oseltamivir phosphate 45 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some
Product containing precisely oseltamivir (as oseltamivir phosphate) 75 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some 1
Product containing precisely oseltamivir phosphate 30 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some 1
Product containing precisely oseltamivir phosphate 30 milligram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Oseltamivir phosphate Inferred relationship Some 1
Product containing precisely oseltamivir phosphate 45 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Oseltamivir phosphate Inferred relationship Some 1
Product containing precisely oseltamivir phosphate 45 milligram/1 each conventional release oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Oseltamivir phosphate Inferred relationship Some 1
Product containing precisely oseltamivir phosphate 30 milligram/1 each conventional release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Oseltamivir phosphate Inferred relationship Some 1
Product containing precisely oseltamivir phosphate 45 milligram/1 each conventional release oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Oseltamivir phosphate Inferred relationship Some 1
Product containing precisely oseltamivir (as oseltamivir phosphate) 75 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oseltamivir phosphate Inferred relationship Some 1
Oseltamivir (as oseltamivir phosphate) 45 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oseltamivir phosphate Inferred relationship Some 1
Oseltamivir (as oseltamivir phosphate) 30 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oseltamivir phosphate Inferred relationship Some 1
Product containing precisely oseltamivir (as oseltamivir phosphate) 12 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oseltamivir phosphate Inferred relationship Some 1
Product containing precisely oseltamivir (as oseltamivir phosphate) 6 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Oseltamivir phosphate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start